In the appropriate clinico-pathological context, the finding of 2 unequivocal positive immunomarker (out of 3 among GPC3, HSP70, and GS) can detect early HCC with a sensitivity of 72% and a specificity of 100% [15]. This evidence concerns the gene GPC3 and hepatocellular carcinoma.